Insider trades
Josh Mandel-Brehm, Director of ProMIS Neurosciences PMN, has filed 1 purchase and 0 sales on the open market. The latest trade was on 05/20.
Josh Mandel-Brehm
Director
- Company
- ProMIS Neurosciences PMN
- First filing
- 24/10/15
- Trades
- 10 trades
- Buys / sales
- 1 / 0
- 12-month net buying
- No record
- Last trade
- 05/20
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/09/11 | 25/09/11 | 6,060 sh | $1.65 | $9,999 | +2.2% |
